BioProtonics is an MR-based diagnostic platform that develops new and sensitive diagnostic tools for ultra efficient operating model.
bioProtonics provides the resolving power needed to measure the ultra-fine tissue changes that are the earliest harbingers of disease, thus enabling the most effective application of therapeutics. The company was founded in 2018 and is headquartered in Santa Barbara, California, United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 21, 2015 | Grant | $150K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |